New cancer clinical trial: Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Published on: May 31, 2018 at 12:00PM
Conditions:   PSA Level Greater Than 0.03;   PSA Progression;   Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7;   Stage II Prostate Adenocarcinoma AJCC v7;   Stage III Prostate Adenocarcinoma AJCC v7
Interventions:   Drug: Antiandrogen Therapy;   Other: Quality-of-Life Assessment;   Radiation: Stereotactic Body Radiation Therapy
Sponsors:   Jonsson Comprehensive Cancer Center;   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2kGas0i